Clinical Trial Detail

NCT ID NCT01132014
Title Autologous OC-DC Vaccine in Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

peritoneal carcinoma

fallopian tube cancer

ovarian cancer

Therapies

Bevacizumab

Dacarbazine

Age Groups: adult

No variant requirements are available.